Tenax Therapeutics Inc.

5.99
0.19 (3.28%)
At close: Apr 28, 2025, 3:59 PM
5.87
-2.00%
After-hours: Apr 28, 2025, 04:44 PM EDT

Tenax Therapeutics Statistics

Share Statistics

Tenax Therapeutics has 4.15M shares outstanding. The number of shares has increased by 102.75% in one year.

Shares Outstanding 4.15M
Shares Change (YoY) 102.75%
Shares Change (QoQ) 16.47%
Owned by Institutions (%) 1.31%
Shares Floating 3.63M
Failed to Deliver (FTD) Shares 1.83K
FTD / Avg. Volume 4.84%

Short Selling Information

The latest short interest is 336.1K, so 8.1% of the outstanding shares have been sold short.

Short Interest 336.1K
Short % of Shares Out 8.1%
Short % of Float 10.13%
Short Ratio (days to cover) 19.54

Valuation Ratios

The PE ratio is -53.71 and the forward PE ratio is -2.69. Tenax Therapeutics's PEG ratio is 0.54.

PE Ratio -53.71
Forward PE -2.69
PS Ratio 0
Forward PS 0.1
PB Ratio 10.28
P/FCF Ratio -63.83
PEG Ratio 0.54
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Tenax Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 20.6, with a Debt / Equity ratio of 0.

Current Ratio 20.6
Quick Ratio 20.6
Debt / Equity 0
Debt / EBITDA -
Debt / FCF 0
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-4.4M
Employee Count 4
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 63.22% in the last 52 weeks. The beta is 1.87, so Tenax Therapeutics's price volatility has been higher than the market average.

Beta 1.87
52-Week Price Change 63.22%
50-Day Moving Average 6.05
200-Day Moving Average 5.06
Relative Strength Index (RSI) 52.41
Average Volume (20 Days) 37.86K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income 0
Net Income -17.6M
EBITDA 0
EBIT n/a
Earnings Per Share (EPS) -0.12
Full Income Statement

Balance Sheet

The company has 94.85M in cash and 0 in debt, giving a net cash position of 94.85M.

Cash & Cash Equivalents 94.85M
Total Debt 0
Net Cash 94.85M
Retained Earnings -314.86M
Total Assets 96.69M
Working Capital 91.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.81M and capital expenditures 0, giving a free cash flow of -14.81M.

Operating Cash Flow -14.81M
Capital Expenditures 0
Free Cash Flow -14.81M
FCF Per Share -0.1
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TENX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for TENX is $16, which is 167.1% higher than the current price. The consensus rating is "Buy".

Price Target $16
Price Target Difference 167.1%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Jan 3, 2024. It was a backward split with a ratio of 1:80.

Last Split Date Jan 3, 2024
Split Type backward
Split Ratio 1:80

Scores

Altman Z-Score -1.12
Piotroski F-Score 3

Advertisement